Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roy A Pleasants

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
The Annals of Pharmacotherapy|September 4, 2018
Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary DiseaseRoy A Pleasants
Pharmacotherapy|September 2, 2006
Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary diseaseRoy A Pleasants
Respiratory Care|May 26, 2018
Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung DiseasesRoy A Pleasants
Annals of the American Thoracic Society|July 12, 2017
Dry Powder Inhalers and Humidity: Another Factor to Consider to Ensure Adequate Lung DeliveryRoy A Pleasants
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 22, 2006
An update on chronic obstructive pulmonary diseaseRoy A Pleasants, Douglas Haden
International Journal of Chronic Obstructive Pulmonary Disease|May 1, 2015
Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPDJinming Gao, Roy A Pleasants
Southern Medical Journal|December 2, 2010
Mortality from chronic obstructive pulmonary disease among adults aged 25 years or older in North CarolinaDavid W Brown, Roy A Pleasants
Respiratory Care|May 26, 2018
Aerosol Delivery Devices for Obstructive Lung DiseasesRoy A Pleasants, Dean R Hess
Annals of the American Thoracic Society|August 8, 2022
Not All Inhaled Medicines Are EqualRoy A Pleasants, Stephen L Tilley
Respiratory Care|June 23, 2023
Current Perspectives of Pharmacotherapies for COPDRoy A Pleasants, James F Donohue
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Annals of Pharmacotherapy|September 4, 2018
Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary DiseaseRoy A Pleasants
Pharmacotherapy|September 2, 2006
Review of guidelines and the literature in the treatment of acute bronchospasm in chronic obstructive pulmonary diseaseRoy A Pleasants
Respiratory Care|May 26, 2018
Clinical Pharmacology of Oral Maintenance Therapies for Obstructive Lung DiseasesRoy A Pleasants
Annals of the American Thoracic Society|July 12, 2017
Dry Powder Inhalers and Humidity: Another Factor to Consider to Ensure Adequate Lung DeliveryRoy A Pleasants
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 22, 2006
An update on chronic obstructive pulmonary diseaseRoy A Pleasants, Douglas Haden
International Journal of Chronic Obstructive Pulmonary Disease|May 1, 2015
Role of the fixed combination of fluticasone and salmeterol in adult Chinese patients with asthma and COPDJinming Gao, Roy A Pleasants
Southern Medical Journal|December 2, 2010
Mortality from chronic obstructive pulmonary disease among adults aged 25 years or older in North CarolinaDavid W Brown, Roy A Pleasants
Respiratory Care|May 26, 2018
Aerosol Delivery Devices for Obstructive Lung DiseasesRoy A Pleasants, Dean R Hess
Annals of the American Thoracic Society|August 8, 2022
Not All Inhaled Medicines Are EqualRoy A Pleasants, Stephen L Tilley
Respiratory Care|June 23, 2023
Current Perspectives of Pharmacotherapies for COPDRoy A Pleasants, James F Donohue
Pageof 5